Liquid crystalline assembly for potential combinatorial chemo–herbal drug delivery to lung cancer cells

References

• AbdelazizHMGaberMAbd-ElwakilMMInhalable particulate drug delivery systems for lung cancer therapy: nanoparticles, microparticles, nanocomposites and nanoaggregatesJ Control Release201826937439229180168
   PubMed Web of Science ®Google Scholar
• SmithRAAndrewsKSBrooksDCancer screening in the United States, 2017: a review of current American Cancer Society guidelines and current issues in cancer screeningCA Cancer J Clin201767210012128170086
   PubMed Web of Science ®Google Scholar
• American Cancer SocietyWhat Is Non-Small Cell Lung Cancer?Atlanta, GAAmerican Cancer Society2016
   Google Scholar
• ZappaCMousaSANon-small cell lung cancer: current treatment and future advancesTransl Lung Cancer Res20165328830027413711
   PubMed Web of Science ®Google Scholar
• MidthunDEEarly detection of lung cancerF1000Res20165739
   Google Scholar
• American Cancer SocietyTreatment Choices for Non-Small Cell Lung Cancer, by StageAtlanta, GAAmerican Cancer Society2017
   Google Scholar
• ChidambaramMManavalanRKathiresanKNanotherapeutics to overcome conventional cancer chemotherapy limitationsJ Pharm Pharm Sci2011141677721501554
   PubMed Web of Science ®Google Scholar
• Chemotherapy And Selective Toxicity [webpage on the Internet]All Answers Ltd.2013 Available from: https://www.ukessays.com/essays/biology/chemotherapy-and-selective-toxicity-biology-essay.php?vref=1Accessed December 28, 2018
   Google Scholar
• ElzoghbyAOElgoharyMMKamelNMImplications of protein- and Peptide-based nanoparticles as potential vehicles for anticancer drugsAdv Protein Chem Struct Biol20159816922125819280
   PubMed Web of Science ®Google Scholar
• CohenMHJohnsonJRWangYCSridharaRPazdurRFDA drug approval summary: pemetrexed for injection (Alimta) for the treatment of non-small cell lung cancerOncologist200510636336815967829
   PubMed Web of Science ®Google Scholar
• PubChem [homepage on the Internet]Compound Database; CID=446556 Available from: https://pubchem.ncbi.nlm.nih.gov/compound/446556Accessed December 3, 2017
   Google Scholar
• AdjeiAAPharmacology and mechanism of action of pemetrexedClin Lung Cancer20045Suppl 2S51S5515117425
   PubMedGoogle Scholar
• ChattopadhyaySMoranRGGoldmanIDPemetrexed: biochemical and cellular pharmacology, mechanisms, and clinical applicationsMol Cancer Ther20076240441717308042
   PubMed Web of Science ®Google Scholar
• FuldADDragnevKHRigasJRPemetrexed in advanced non-small-cell lung cancerExpert Opin Pharmacother20101181387140220446853
   PubMed Web of Science ®Google Scholar
• HoCDaviesAMSanghaRSPhase I/II trial of pemetrexed plus nab-paclitaxel in advanced solid tumor patients with emphasis on non-small cell lung cancerInvest New Drugs20133161587159124013936
   PubMedGoogle Scholar
• MahmudFJeonOCAlamFOral pemetrexed facilitates low-dose metronomic therapy and enhances antitumor efficacy in lung cancerJ Control Release201828416017029908222
   PubMed Web of Science ®Google Scholar
• El-FarSWHelmyMWKhattabSNBekhitAAHusseinAAElzoghbyAOPhytosomal bilayer-enveloped casein micelles for code-livery of monascus yellow pigments and resveratrol to breast cancerNanomedicine201813548149929376765
   PubMed Web of Science ®Google Scholar
• KabaryDMHelmyMWElkhodairyKAFangJYElzoghbyAOHyaluronate/lactoferrin layer-by-layer-coated lipid nanocarriers for targeted co-delivery of rapamycin and berberine to lung carcinomaColloids Surf B Biointerfaces201816918319429775813
   PubMed Web of Science ®Google Scholar
• SabraSAElzoghbyAOSheweitaSASelf-assembled amphiphilic zeinlactoferrin micelles for tumor targeted co-delivery of rapamycin and wogonin to breast cancerEur J Pharm Biopharm201812815616929689288
   PubMed Web of Science ®Google Scholar
• ElzoghbyAOEl-LakanySAHelmyMWAbu-SerieMMElgindyNAShell-crosslinked zein nanocapsules for oral codelivery of exemestane and resveratrol in breast cancer therapyNanomedicine (Lond)201712242785280529094642
   PubMed Web of Science ®Google Scholar
• DonnellyLENewtonRKennedyGEAnti-inflammatory effects of resveratrol in lung epithelial cells: molecular mechanismsAm J Physiol Lung Cell Mol Physiol20042874L774L78315180920
   PubMed Web of Science ®Google Scholar
• BishayeeACancer prevention and treatment with resveratrol: from rodent studies to clinical trialsCancer Prev Res (Phila)20092540941819401532
   PubMed Web of Science ®Google Scholar
• VaroniEMLo FaroAFSharifi-RadJIritiMAnticancer molecular mechanisms of resveratrolFront Nutr20163827148534
   PubMed Web of Science ®Google Scholar
• HamzaRZEl-ShenawyNSAnti-inflammatory and antioxidant role of resveratrol on nicotine-induced lung changes in male ratsToxicol Rep2017439940728959665
   PubMedGoogle Scholar
• ElzoghbyAEditorial (Thematic issue: nanocarriers based on natural polymers as platforms for drug and gene delivery applications)Curr Pharm Des201622223303330427165162
   PubMed Web of Science ®Google Scholar
• ElzoghbyAFreagMMamdouhHElkhodairyKZein-based nanocarriers as potential natural alternatives for drug and gene delivery: Focus on cancer therapyCurr Pharm Des201723355261527128641543
   PubMedGoogle Scholar
• ChenRSKoJCChiuHCPemetrexed downregulates ERCC1 expression and enhances cytotoxicity effected by resveratrol in human nonsmall cell lung cancer cellsNaunyn Schmiedebergs Arch Pharmacol2013386121047105923912706
   PubMedGoogle Scholar
• SummerlinNSooEThakurSQuZJambhrunkarSPopatAResveratrol nanoformulations: challenges and opportunitiesInt J Pharm2015479228229025572692
   PubMed Web of Science ®Google Scholar
• AngelovaAAngelovBMutafchievaRLesieurSCouvreurPSelf-assembled multicompartment liquid crystalline lipid carriers for protein, peptide, and nucleic acid drug deliveryAcc Chem Res201144214715621189042
   PubMed Web of Science ®Google Scholar
• FreagMSElnaggarYSAbdelmonsifDAAbdallahOYStealth, bio-compatible monoolein-based lyotropic liquid crystalline nanoparticles for enhanced aloe-emodin delivery to breast cancer cells: in vitro and in vivo studiesInt J Nanomedicine201611114799481827703348
   PubMedGoogle Scholar
• LiuRWangSFangSLiquid crystalline nanoparticles as an ophthalmic delivery system for tetrandrine: development, characterization, and in vitro and in vivo evaluationNanoscale Res Lett201611125427188974
   PubMedGoogle Scholar
• ElzoghbyAOAbd-ElwakilMMAbd-ElsalamKElsayedMTHashemYMohamedONatural polymeric nanoparticles for brain-targeting: implications on drug and gene deliveryCurr Pharm Des201622223305332326845323
   PubMed Web of Science ®Google Scholar
• ElzoghbyAOHemasaALFreagMSHybrid protein-inorganic nanoparticles: from tumor-targeted drug delivery to cancer imagingJ Control Release201624330332227794493
   PubMed Web of Science ®Google Scholar
• GaberMMedhatWHanyMSaherNFangJYElzoghbyAProtein-lipid nanohybrids as emerging platforms for drug and gene delivery: challenges and outcomesJ Control Release2017254759128365294
   PubMed Web of Science ®Google Scholar
• SabraSAbdelmoneemMAbdelwakilMSelf-assembled nano-carriers based on amphiphilic natural polymers for anti-cancer drug delivery applicationsCurr Pharm Des201723355213522928552068
   PubMedGoogle Scholar
• SpicerPTHaydenKLLynchMLOfori-BoatengABurnsJLNovel process for producing cubic liquid crystalline nanoparticles (Cubosomes)Langmuir2001171957485756
   Web of Science ®Google Scholar
• DevrimBBozkirADesign and evaluation of hydrophobic ion-pairing complexation of lysozyme with sodium dodecyl sulfate for improved encapsulation of hydrophilic peptides/proteins by lipid-polymer hybrid nanoparticlesJ Nanomed Nanotechnol201561259
   Google Scholar
• MeyerJDManningMCHydrophobic ion pairing: altering the solubility properties of biomoleculesPharm Res19981521881939523302
   PubMed Web of Science ®Google Scholar
• SwarnakarNKThankiKJainSBicontinuous cubic liquid crystalline nanoparticles for oral delivery of doxorubicin: implications on bioavailability, therapeutic efficacy, and cardiotoxicityPharm Res20143151219123824218223
   PubMed Web of Science ®Google Scholar
• ElzoghbyAOMostafaSKHelmyMWElDemellawyMASheweitaSASuperiority of aromatase inhibitor and cyclooxygenase-2 inhibitor combined delivery: hyaluronate-targeted versus PEGylated protamine nanocapsules for breast cancer therapyInt J Pharm20175291–217819228663087
   PubMed Web of Science ®Google Scholar
• SwarnakarNKThankiKJainSBicontinuous cubic liquid crystalline nanoparticles for oral delivery of doxorubicin: implications on bioavailability, therapeutic efficacy, and cardiotoxicityPharm Res20143151219123824218223
   PubMed Web of Science ®Google Scholar
• ElgindyNElkhodairyKMolokhiaAElzoghbyABiopolymeric nanoparticles for oral protein delivery: design and in vitro evaluationJ Nanomed Nanotechnol20110203110
   Google Scholar
• ElzoghbyAOMostafaSKHelmyMWEldemellawyMASheweitaSAMulti-reservoir phospholipid shell encapsulating protamine nanocapsules for co-delivery of letrozole and celecoxib in breast cancer therapyPharm Res20173491956196928643236
   PubMed Web of Science ®Google Scholar
• KhattabSNAbdel NaimSEEl-SayedMDesign and synthesis of new s-triazine polymers and their application as nanoparticulate drug delivery systemsNew J Chem2016401195659578
   Web of Science ®Google Scholar
• ElzoghbyAOVranicBZSamyWMElgindyNASwellable floating tablet based on spray-dried casein nanoparticles: near-infrared spectral characterization and floating matrix evaluationInt J Pharm20154911–211312226095913
   PubMedGoogle Scholar
• FreagMSHyaluronate-lipid nanohybrids: fruitful harmony in cancer targetingCurr Pharm Des201723355283529128552066
   PubMedGoogle Scholar
• FreagMSElnaggarYSAbdelmonsifDAAbdallahOYLayer-by-layer-coated lyotropic liquid crystalline nanoparticles for active tumor targeting of rapamycinNanomedicine (Lond)201611222975299627785978
   PubMed Web of Science ®Google Scholar
• DeshpandeSVenugopalERamagiriSBellareJRKumaraswamyGSinghNEnhancing cubosome functionality by coating with a single layer of poly-ε-lysineACS Appl Mater Interfaces2014619171261713325184793
   PubMed Web of Science ®Google Scholar
• JainVSwarnakarNKMishraPRPaclitaxel loaded PEGylated gleceryl monooleate based nanoparticulate carriers in chemotherapyBiomaterials201233297206722022809646
   PubMed Web of Science ®Google Scholar
• DeshpandeSSinghNInfluence of cubosome surface architecture on its cellular uptake mechanismLangmuir201733143509351628325047
   PubMedGoogle Scholar
• Harush-FrenkelODebottonNBenitaSAltschulerYTargeting of nanoparticles to the clathrin-mediated endocytic pathwayBiochem Biophys Res Commun20073531263217184736
   PubMed Web of Science ®Google Scholar
• LiQYanoSOginoHThe therapeutic efficacy of anti vascular endothelial growth factor antibody, bevacizumab, and pemetrexed against orthotopically implanted human pleural mesothelioma cells in severe combined immunodeficient miceClin Cancer Res200713195918592517908988
   PubMed Web of Science ®Google Scholar
• SahinEBaycuCKoparalATBurukoglu DonmezDBekturEResveratrol reduces IL-6 and VEGF secretion from co-cultured A549 lung cancer cells and adipose-derived mesenchymal stem cellsTumour Biol20163767573758226687643
   PubMedGoogle Scholar
• LuoTLoira-PastorizaCPatilHPPEGylation of paclitaxel largely improves its safety and anti-tumor efficacy following pulmonary delivery in a mouse model of lung carcinomaJ Control Release2016239627127515664
   PubMed Web of Science ®Google Scholar
• WuJDengCMengFZhangJSunHZhongZHyaluronic acid coated PLGA nanoparticulate docetaxel effectively targets and suppresses orthotopic human lung cancerJ Control Release2017259768228027947
   PubMed Web of Science ®Google Scholar
• KitadaMKoyaDRenal protective effects of resveratrolOxid Med Cell Longev20132013117
   Google Scholar
• WangYJiangYFanXHepato-protective effect of resveratrol against acetaminophen-induced liver injury is associated with inhibition of CYP-mediated bioactivation and regulation of SIRT1-p53 signaling pathwaysToxicol Lett20152362828925956474
   PubMed Web of Science ®Google Scholar
• ChenWMShawLHChangPJHepatoprotective effect of resveratrol against ethanol-induced oxidative stress through induction of superoxide dismutase in vivo and in vitroExp Ther Med20161141231123827073428
   PubMedGoogle Scholar
• OsmanAMTelitySADamanhouriZAChemosensitizing and nephroprotective effect of resveratrol in cisplatin-treated animalsCancer Cell Int2015151625709558
   PubMedGoogle Scholar